Abstract:Acute lung injury (ALI) is a severe clinical condition with high mortality, characterized by rapid onset and limited treatment options. The pathogenesis of ALI involves inflammation and oxidative stress. The polysaccharide salecan, a water-soluble β-(1,3)-D-glucan, has been found to possess numerous pharmaceutical effects, including anti-inflammatory properties, inhibition of oxidative stress, and anti-fatigue effects. This study aims to investigate the protective effect and underlying mechanism of salecan against LPS-induced ALI in mice. Using an in vivo LPS-induced ALI mouse model and an in vitro RAW264.7 cell system, we investigated the role of salecan in ALI with various experimental approaches, including histological staining, quantitative real-time PCR, flow cytometry, western blot analysis, and other relevant assays. Pre-treatment with salecan effectively attenuated LPS-induced ALI in vivo, reducing the severity of pulmonary edema, inflammation, and oxidative stress. NMR-based metabolomic profiling analysis revealed that salecan attenuated LPS-induced metabolic imbalances associated with ALI. Furthermore, salecan downregulated Keap1 and upregulated Nrf2 and HO-1 protein levels, indicating its modulation of the Keap1-Nrf2/HO-1 signaling pathway as a potential mechanism underlying its protective effects against ALI. In vitro studies on RAW264.7 cells revealed that salecan exhibited binding affinity towards macrophages, thereby alleviating LPS-induced apoptosis and inflammation, which underpin its therapeutic potential against ALI. Our study suggests that salecan can alleviate LPS-induced ALI by modulating oxidative stress, inflammatory response, and apoptosis through the activation of the Keap1-Nrf2/HO-1 pathway. These findings provide novel insights into the potential therapeutic use of salecan for the treatment of ALI.

Results of a 90-day safety assessment study in mice fed a glucan produced by Agrobacterium sp. ZX09.

A Novel Soluble Beta-1,3-D-Glucan Salecan Reduces Adiposity And Improves Glucose Tolerance In High-Fat Diet-Fed Mice

Salecan Diet Increases Short Chain Fatty Acids and Enriches Beneficial Microbiota in the Mouse Cecum.

Supplementation of the diet with Salecan attenuates the symptoms of colitis induced by dextran sulphate sodium in mice.

Salecan Enhances the Activities of Β-1,3-glucanase and Decreases the Biomass of Soil-Borne Fungi.

Rheological properties of Salecan as a new source of thickening agent

Salecan protected against concanavalin A-induced acute liver injury by modulating T cell immune responses and NMR-based metabolic profiles.

A Novel Soluble Beta-Glucan Salecan Protects Against Acute Alcohol-Induced Hepatotoxicity in Mice

Protective Effects of Salecan Against Carbon Tetrachloride-Induced Acute Liver Injury in Mice

Compositional and Animal Feeding Assessments of a Novel Herbicide-Tolerant Maize Variety

Soluble Beta-Glucan Salecan Improves Vaginal Infection of Candida Albicans in Mice

Identification of Substituent Groups and Related Genes Involved in Salecan Biosynthesis in Agrobacterium Sp. ZX09

Preclinical Safety Evaluation of Oral Drug of Human Granulocyte-Macrophage Colony-Stimulating Factor Expressed in Silkworm Pupae As Bioreactor

Dietary salecan reverts partially the metabolic gene expressions and NMR-based metabolomic profiles from high-fat-diet-induced obese rats.

Orally Administered Salecan Ameliorates Methotrexate-Induced Intestinal Mucositis in Mice

Salecan ameliorates LPS-induced acute lung injury through regulating Keap1-Nrf2/HO-1 pathway in mice

Subchronic toxicity of yeast β-glucan

Safety evaluation of genetically modified DAS-40278-9 maize in a subchronic rodent feeding study.

Salecan confers anti-inflammatory effects in liver injury via regulating gut microbiota and its metabolites

Safety Assessment of Synechococcus Sp. PCC 7002 Biomass: Genotoxicity, Acute and Subchronic Toxicity Studies.

Laxative Effects of Salecan on Normal and Two Models of Experimental Constipated Mice